BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Trimetazidine

A vasodilator used in angina of effort or ischemic heart disease.

300+ PubMed studies analyzed · 55 RCTs · Evidence Score: 54.2

Research Domains

Trimetazidine has been studied across 19 research domains including ❤️ Cardiovascular, 🔥 Metabolic, ⚡ Energy & Fatigue, 🔬 Inflammation, 🧘 Stress & Anxiety. The primary research focus is ❤️ Cardiovascular with 37% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Trimetazidine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Nylidrin
2 shared targets
Dibucaine
2 shared targets
Lynestrenol
2 shared targets
Promethazine
2 shared targets
Nortriptyline
2 shared targets
Amoxapine
2 shared targets
Miconazole
2 shared targets
Amitriptyline
2 shared targets
Fluspirilene
2 shared targets
Perphenazine
2 shared targets
Loading evidence profile...

This evidence profile for Trimetazidine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.